Marsh & McLennan Companies, Inc.
MRSHMarsh & McLennan Companies, Inc. is cheap for a reason. The P/BV sits at the 7th percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: the P/BV sits at the 7th percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn.
The price is topping out (3 weeks in) while the P/BV sits at the 7th percentile of its own 5-year range. Underneath, the last four quarters read deteriorating — profit −15.6% year on year, with the the net margin at 15.7%. What settles it: whether the quarters turn before the discount closes.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Marsh & McLennan Companies, Inc. trades at $192, losing momentum at the top and 3 weeks into that stage. That is +8.3% against its own 200-day average. It sits at 64% of a 52-week range of $160 to $211. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks.
Today the stock is losing momentum at the top — week 3 of stage 3. At $192 it trades +8.3% versus its 200-day average and sits at 64% of its 52-week range ($160–$211).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +186% while the S&P 500 moved +248% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 2 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/BV sits at the 7th percentile of its own range.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Marsh & McLennan Companies, Inc. trades at 5.8× P/BV, near the bottom of its own range — cheaper only 7% of the time. Its long-run median P/BV is 7.9×, measured across 5.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 5.8× is near the bottom of its own range — cheaper only 7% of the time, against a long-run median of 7.9× measured over 5.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year book value grew while the price moved −8.7% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +5.5%/yr price move, ~+9.8%/yr came from book-value growth and ~−4.3 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Marsh & McLennan Companies, Inc. reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 27.1% and holding. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +10.3% | +9.2% | — | — |
| Profit | +2.7% | +11.0% | — | — |
| EPS | +3.1% | +11.8% | — | — |
| Stock price | −8.7% | +0.6% | +5.5% | +11.3% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
46.0/100 — rank 7 of 15 in Insurance Brokers · 60% evidence confidence
Marsh & McLennan Companies, Inc. scores 46.0 out of 100 against the 15 companies it is compared with in Insurance Brokers, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 16.7 + 15.5 + 6.6 + 7.2 = 46. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Marsh & McLennan Companies, Inc. reported $7.6 B of income in the Mar 26 quarter, +7.6% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 8.0% a year. The last full year, FY25, came in at $27.0 B. The last four reported quarters add to $27.5 B.
Marsh & McLennan Companies, Inc. reported $7.6 B of income in the Mar 26 quarter, +7.6% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 8.0% a year. The last full year, FY25, came in at $27.0 B. The last four reported quarters add to $27.5 B.
FY25 revenue came in at $27.0 B (+10.3% on the year), capping 4 years at 8.0% compound. The latest quarter (Mar 26) printed $7.6 B, +7.6% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +9.9% growth against the decade's 8.0% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +9.8% over the last 4 quarters against +8.7%/yr over the last 8 — stabilising; TTM profit −2.2% vs +0.4%/yr — stabilising.
→ Revenue grew — did the net margin hold as it scaled? Next: 15.7% this quarter (−4.3 pp YoY).
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Marsh & McLennan Companies, Inc.'s net margin is 15.7% in the Mar 26 quarter, −4.3 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 14.9% to 16.8%. The current quarter sits inside that band.
Marsh & McLennan Companies, Inc.'s net margin is 15.7% in the Mar 26 quarter, −4.3 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 14.9% to 16.8%. The current quarter sits inside that band.
The latest quarter's net margin is 15.7%, −4.3 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 14.9%–16.8%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
→ The net margin slipped — did that reach the bottom line? Next: profit −15.6% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Marsh & McLennan Companies, Inc. earned $1.2 B of net profit in the Mar 26 quarter, −15.6% year on year. Full-year FY25 profit was $4.2 B. The 4-year compound rate is 7.5%. That is 15.7% of the quarter's revenue. The same quarter a year earlier earned $1.4 B.
Marsh & McLennan Companies, Inc. earned $1.2 B of net profit in the Mar 26 quarter, −15.6% year on year. Full-year FY25 profit was $4.2 B. The 4-year compound rate is 7.5%. That is 15.7% of the quarter's revenue. The same quarter a year earlier earned $1.4 B.
Mar 26 profit was $1.2 B, −15.6% year on year. On the full year, FY25 printed $4.2 B (+2.7%), and the 4-year compound rate is 7.5%.
🚨 Why profit moved: revenue contributed +7.6% and the margin −4.3 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −0.7% vs revenue +9.9%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
→ Profit is up — how clean is the loan book behind it? Next: we hold no quarterly loan-book numbers — the section says so plainly.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Marsh & McLennan Companies, Inc., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
→ Behind the profits — is the book itself still growing? Next: revenue grew +10.3% in FY25.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Marsh & McLennan Companies, Inc.'s revenue grew +10.3% in FY25 to $27.0 B, so the book is growing. The latest quarter ran +7.6% year on year. The net margin on that income is 15.7%, −4.3 percentage points against a year ago.
FY25 revenue was $27.0 B, +10.3% on the year, and the latest quarter ran +7.6% year on year. The net margin on that revenue is 15.7% this quarter (−4.3 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
→ Does all of this actually earn its keep on equity? Next: ROE is 26%.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Marsh & McLennan Companies, Inc. earns a return on equity of 28% in FY25. Its trough over the ladder below was 28% in FY25. On the asset side every $100 of the balance sheet earned about $7.24, which is the return before leverage is applied.
FY25 ROE came in at 28%. On assets, the latest reading is about 7.24% — every $100 the bank deploys earns roughly $7.24 a year. That clears the bar a bank must beat for its book value to compound.
Why: the ROE ladder shows the move; the deposit-cost and provisioning drivers behind it sit below what we hold.
→ Who owns this bank, and are they adding or leaving? Next: short interest is 1.4% of the float.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Marsh & McLennan Companies, Inc. paid $3.60 per share over the last four reported quarters, up 10.4% on a year ago. The most recent declaration was $0.90 for Mar 26. Against the current price of $192 that is a trailing yield of 1.87%, measured on dividends already paid rather than on a forecast.
Marsh & McLennan Companies, Inc. paid $3.60 per share over the last four reported quarters, up 10.4% on a year ago. The most recent declaration was $0.90 for Mar 26. Against the current price of $192 that is a trailing yield of 1.87%, measured on dividends already paid rather than on a forecast.
Marsh & McLennan Companies, Inc. paid $3.60 per share across the last four reported quarters, most recently $0.90 for Mar 26. That is up 10.4% against the same quarter a year earlier. Against the current price of $192 the trailing twelve months work out to 1.87% — trailing dividends measured against today's price, not a forward estimate.
→ A payout is cash leaving the business. Next: what the balance sheet looks like behind it.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
→ Who owns this, and are they adding or leaving? Next: short interest is 1.4% of the float.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
1.4% of Marsh & McLennan Companies, Inc.'s tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 2.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 1.4% of the float is sold short, and at typical trading volumes it would take about 2.6 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Marsh & McLennan Companies, Inc.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | P/BV | Mkt cap | Revenue | EPS | ROE | Stage |
|---|---|---|---|---|---|---|
| Marsh & McLennan Companies, Inc. this page | 5.8× | $92B | Consistent | |||
| Aon plc | 8.3× | $81B | Turning around | |||
| Arthur J. Gallagher & Co. | 2.9× | $68B | Mixed | |||
| Willis Towers Watson Public Limited Company | 3.7× | $30B | Mixed | |||
| Brown & Brown, Inc. | 1.9× | $25B | Mixed | |||
| Erie Indemnity Company | 5.4× | $13B | Topping out | |||
| Neptune Insurance Holdings Inc. | — | $4B | No read | |||
| The Baldwin Insurance Group, Inc. | 2.9× | $4B | No read | |||
| Accelerant Holdings | 4.7× | $3B | No read | |||
| CorVel Corporation | 8.0× | $3B | Turning around | |||
| Goosehead Insurance, Inc. | — | $2B | Mixed | |||
| TWFG, Inc. | 5.7× | $1B | Mixed | |||
| Ethos Technologies Inc. | 2.7× | $1B | No read | |||
| Crawford & Company | 3.0× | $1B | Deteriorating | |||
| Crawford & Company | 2.8× | $1B | Deteriorating | |||
| AIFU Inc. | 0.5× | $0B | Mixed | |||
| Kepler Group Limited | 182.0× | $0B | — | — | — | — |
| SelectQuote, Inc. | 0.3× | $0B | No read |
Frequently asked questions
What is Marsh & McLennan Companies, Inc.'s stock price today?
Marsh & McLennan Companies, Inc. trades at $192, −8.7% over the past year. The company is valued at $92.0 B. The stock sits at 64% of its 52-week range of $160–$211, +8.3% versus its 200-day average. On the tape, the price is topping out, 3 weeks in. — as of 29 July 2026.
What were Marsh & McLennan Companies, Inc.'s latest quarterly results?
Marsh & McLennan Companies, Inc. reported total income of $7.6 B and net profit of $1.2 B for the Mar 26 quarter. Income rose 7.6% and profit fell 15.6% year on year. Earnings per share were $2.36. The net margin was 15.7%, 4.3 pp lower than a year earlier. — as of 29 July 2026.
What is Marsh & McLennan Companies, Inc.'s revenue?
Marsh & McLennan Companies, Inc. reported revenue of $7.6 B in the Mar 26 quarter, +7.6% year on year. For the full FY25 fiscal year, revenue was $27.0 B (+10.3%). Over the last 4 years revenue compounded at 8.0% a year. — as of 29 July 2026.
What is Marsh & McLennan Companies, Inc.'s profit?
Marsh & McLennan Companies, Inc. earned $1.2 B of net profit in the Mar 26 quarter, −15.6% year on year. Full-year FY25 profit was $4.2 B. The net margin ran 15.7% in the latest quarter. — as of 29 July 2026.
What is Marsh & McLennan Companies, Inc.'s market cap?
Marsh & McLennan Companies, Inc.'s market capitalisation is $92.0 B at a stock price of $192. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.
What is Marsh & McLennan Companies, Inc.'s P/BV ratio?
Marsh & McLennan Companies, Inc. trades at a P/BV of 5.8×, at the 7th percentile of its own 5-year range, against a long-run median of 7.9×. This is a comparison with the stock's own history, not a value call — as of 29 July 2026.
Does Marsh & McLennan Companies, Inc. pay a dividend?
Yes — Marsh & McLennan Companies, Inc. declared $0.90 per share for Mar 26, and $3.60 per share across the last four reported quarters. The latest quarter is up 10.4% on the same quarter a year earlier. — as of 29 July 2026.
What is Marsh & McLennan Companies, Inc.'s dividend per share?
Marsh & McLennan Companies, Inc.'s most recently declared dividend is $0.90 per share for Mar 26, giving $3.60 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 29 July 2026.
What is Marsh & McLennan Companies, Inc.'s dividend yield?
Marsh & McLennan Companies, Inc.'s trailing dividend yield is 1.87%: $3.60 declared per share across the last four reported quarters, against a share price of $192. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 29 July 2026.
Is Marsh & McLennan Companies, Inc. overvalued?
On its own history, Marsh & McLennan Companies, Inc. looks cheap against its own history: its P/BV of 5.8× has been cheaper only 7% of the time in 5 years (long-run median 7.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 29 July 2026.
Is Marsh & McLennan Companies, Inc. growing?
Not right now — Marsh & McLennan Companies, Inc.'s latest numbers are shrinking: latest-quarter revenue +7.6% year on year, profit −15.6%, and the the net margin −4.3 pp at 15.7%. The 4-year compound rates are 8.0% (revenue) and 7.5% (profit). The earnings engine currently reads: deteriorating — as of 29 July 2026.
How is Marsh & McLennan Companies, Inc. performing?
Marsh & McLennan Companies, Inc. is topping out, 3 weeks in. Its latest quarter's income rose 7.6% and profit fell 15.6% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 29 July 2026.
What stage is Marsh & McLennan Companies, Inc. in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 27.1% and holding. The read comes from the last 12 quarters of growth (revenue growth +9.8% latest, profit growth −2.2% latest, eps growth −2.0% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 29 July 2026.
Is Marsh & McLennan Companies, Inc. in an uptrend?
It is stalling — the price is topping out (week 3 of stage 3), trading +8.3% versus its 200-day average and at 64% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 29 July 2026.
Is Marsh & McLennan Companies, Inc. beating the market?
On recent form, yes — Marsh & McLennan Companies, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 2 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +186% against the S&P 500's +248% — behind the index over the full window. — as of 29 July 2026.
Will Marsh & McLennan Companies, Inc.'s stock price go up?
This page publishes no price forecast for Marsh & McLennan Companies, Inc. What it measures instead: the stock price is $192, the price is topping out 3 weeks in. Its P/BV of 5.8× sits at the 7th percentile of its own 5-year range. — as of 29 July 2026.
Is the market betting against Marsh & McLennan Companies, Inc.?
No — short interest is 1.4% of Marsh & McLennan Companies, Inc.'s tradable float, about 2.6 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.
Is Marsh & McLennan Companies, Inc.'s loan book healthy?
We do not hold quarterly loan-book quality numbers for Marsh & McLennan Companies, Inc., so this page says that plainly. The cleanest available reads are revenue growth (+10.3% in FY25) and the net margin on it (15.7%) — as of 29 July 2026.
Where is Marsh & McLennan Companies, Inc. in its business cycle?
Marsh & McLennan Companies, Inc.'s FY25 net margin was 15.7%, against a 5-year band of 14.9%–16.8%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 15.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.
What could break the Marsh & McLennan Companies, Inc. story?
The sharpest disagreement: the P/BV sits at the 7th percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.
Is Marsh & McLennan Companies, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Marsh & McLennan Companies, Inc. is cheap for a reason. The P/BV sits at the 7th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the quarters turn before the discount closes. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.